[HTML][HTML] 177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry
A Abouzayed, K Seitova, F Lundmark… - Frontiers in …, 2023 - frontiersin.org
Introduction Prostate specific membrane antigen (PSMA), highly expressed in metastatic
castration-resistant prostate cancer (mCRPC), is an established therapeutic target …
castration-resistant prostate cancer (mCRPC), is an established therapeutic target …
[HTML][HTML] 177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry
A Abouzayed, K Seitova, F Lundmark… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Methods BQ7876 was synthesized and labeled with Lu-177. Specificity and affinity of [177
Lu] Lu-BQ7876 to PSMA-expressing PC3-pip cells was evaluated and its processing after …
Lu] Lu-BQ7876 to PSMA-expressing PC3-pip cells was evaluated and its processing after …
177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry
A Abouzayed, K Seitova, F Lundmark… - Frontiers in …, 2023 - diva-portal.org
Methods: BQ7876 was synthesized and labeled with Lu-177. Specificity and affinity of
[177Lu] Lu-BQ7876 to PSMA-expressing PC3-pip cells was evaluated and its processing …
[177Lu] Lu-BQ7876 to PSMA-expressing PC3-pip cells was evaluated and its processing …
177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry
A Abouzayed, K Seitova, F Lundmark… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Prostate specific membrane antigen (PSMA), highly expressed in metastatic
castration-resistant prostate cancer (mCRPC), is an established therapeutic target …
castration-resistant prostate cancer (mCRPC), is an established therapeutic target …
177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry.
A Abouzayed, K Seitova, F Lundmark… - Frontiers in …, 2023 - europepmc.org
Methods BQ7876 was synthesized and labeled with Lu-177. Specificity and affinity of [177
Lu] Lu-BQ7876 to PSMA-expressing PC3-pip cells was evaluated and its processing after …
Lu] Lu-BQ7876 to PSMA-expressing PC3-pip cells was evaluated and its processing after …